FederalBill S-243In committee — Senate
Bill S-243: National Framework for Women’s Health in Canada Act
Sponsor: Sen. Danièle HenkelIntroduced December 9, 2025Last checked August 28, 2026
Read the official text on parl.caOfficial version — LEGISinfo, Parliament of Canada
What this bill does
This bill requires the Minister of Health to develop a national framework for women's health in Canada, including measures to improve health outcomes, invest in women's health research and innovation, enhance healthcare professional training, and improve healthcare access for women, particularly those in underserved communities.
Plain-language summary by Legisail.
Business impact
This bill primarily affects businesses in the healthcare, health research, pharmaceutical, and health innovation sectors across all provinces and territories. Companies involved in health-focused entrepreneurship—particularly women-led health startups and firms commercializing health research—could benefit from new collaboration pathways between public systems and the private sector. Healthcare training providers and professional education organizations may need to develop or update curricula related to women's health. The framework also signals potential new funding and investment opportunities for businesses of all sizes engaged in health research, medical devices, or healthcare delivery, especially those serving rural, remote, or equity-deserving populations.
Does this apply to you?
Your own business or clients you watch for — tell Legisail what matters and it checks every bill and regulation against it.
Where this bill is
First ReadingDecember 9, 2025
Second ReadingMarch 26, 2026
CommitteeApril 3, 2026
Next: Third Reading vote
Legisail watches this for you
Tell Legisail about your business and it checks every new bill and regulation against it — you only hear about the ones that matter.
Create a free accountFree · 30 seconds · No credit cardAt a glance
- Bill number
- S-243
- Type
- Senate Public Bill
- Current chamber
- Senate
- Jurisdiction
- Federal
- Session
- 45-1